Evinova:
Your Partner in Respiratory Studies
Digital solutions built by pharma – for respiratory studies that are faster, more patient-centric, and designed for high quality lung function data to be collected at home.
Innovation in respiratory medicine is reshaping how clinical trials are designed and run. Evinova delivers science-based, evidence-led, and human-experience-driven solutions that simplify study conduct, reduce patient burden, and generate robust endpoints at scale.
Most asthma and COPD studies still rely on exacerbation events and clinic-based spirometry, making trials long, costly, and demanding for patients. Evinova is changing that – with proven solutions like the CompEx digital endpoint and remote lung function monitoring.
Join us in advancing smarter, patient-centric respiratory trials. Let’s innovate together.
Digital approach adds value for respiratory studies
COPD
(global outcomes study)
A large COPD program that adopted Evinova’s unified digital approach reported
COPD (Phase 2a) – novel endpoint & home measurements
Using COPDCompEx as the endpoint and enabling at home spirometry with AI over-read, the modeled design showed potential for
What’s possible, more broadly
Independent and internal analyses indicate ~70% of trial assessments can be conducted remotely – with meaningful reductions in on-site visits when appropriate assessments and technologies are selected for the protocol.
Scale you can trust
Evinova’s trial solutions are deployed globally, helping sponsors run respiratory studies consistently across regions.
Experience matters:
a seasoned respiratory team
Built by pharma, for pharma – Evinova simplifies global respiratory trials.
We understand the real-world challenges faced by study teams, sites, and patients. That's why our solutions are designed to streamline operations and reduce burden with:
Single sign-on and real-time dashboards
-
Home supply
-
Telehealth
-
Remote coached spirometry
-
Digital CompEx endpoints
Backed by digital strategists, scientists, clinicians, and trial delivery experts, Evinova partners with you to craft the right digital strategy for your program or study, ensuring efficient conduct and high-quality data to support your outcomes.
Shape the future of respiratory research with Evinova.
Fit-for purpose digital solutions for respiratory clinical trials
Remote & Virtually Coached Respiratory Assessments
Enable more frequent, high-quality lung function data collection without clinic travel.
-
At home spirometry with real time coaching and quality grading.
-
Peak Expiratory Flow (PEF) and symptom ePRO streams that can power composite endpoints to improve trial efficiency.
-
Composite Endpoint for Exacerbations (CompEx) combines multiple clinical indicators – such as symptom ratings, reliever medication use, and PEF – to detect clinically relevant deterioration earlier and more reliably than traditional exacerbation definitions.
-
Upcoming at-site FeNO and Spirometry Kiosk functionality will provide another flexible and patient-centric data collection option.
-
Optional support for FeNO, pulse oximetry (SpO₂) and respiratory rate via connected devices – in one patient app and unified site portal.
What it means for your study:
Evinova’s end-to-end respiratory solution accelerates your study timelines, eases patient and site burden, and delivers reliable, high-quality outcomes.
Reduce Patient Burden through Remote Data Capture
Evinova’s Unified Trial Solution (UTS) integrates eCOA/ePRO, remote patient monitoring, telehealth, connected devices, home supply and study info into a single experience for participants – backed by a consolidated site workspace.
-
Library of validated eCOA instruments, telehealth for virtual visits, and a unified device experience to keep tasks simple and compliant.
-
Based on Evinova’s analysis and published evidence, ~70% of critical assessments in trials can be performed remotely – substantially reducing travel and time costs for participants.
Design Smarter Respiratory Studies with Data & AI
With Evinova’s Study Design & Optimization tool, teams can explore design options, trade-offs and impacts across cost, complexity, experience, speed and carbon emissions – helping you land on a design that’s both operationally feasible and patient centric.
-
Cost estimation and scenario comparison to accelerate decision making.
-
Sustainability insights and carbon reduction opportunities embedded in the planning workflow.
Why Evinova for respiratory?
Built inside biopharma, for the sector
We combine clinical and regulatory know-how with rigor and human-centered-design: science-based, evidence-led, human-experience-driven.
End-to-end, yet modular
Start with eCOA + home spirometry, then add remote patient monitoring, telehealth, home supply, adjudication and more as your protocol needs evolve.
Operational excellence
Consolidated site tools, streamlined data flows, and quality controls to reduce admin burden while protecting data integrity.
Ready to plan your next respiratory study?
Whether your protocol includes at-site or remote spirometry, FeNO, or explores digital composites like CompEx for asthma and COPD – Evinova’s End-to-End Respiratory Solution is built to meet your needs.
It will support accelerated timelines, reduce patient and site burden, and deliver reliable, high-quality outcomes through a seamless digital experience.
